Who owns FENC?
Institutional ownership of Fennec Pharmaceuticals Inc. from Form 13F, Q2 2026
105 institutional managers reported holding Fennec Pharmaceuticals Inc. (FENC) in Form 13F filings for Q2 2026, with 16,313,727 shares worth $175M. The largest reported holder was Rosalind Advisors, Inc. Managers that filed both quarters added a net 113,571 shares (+0.7%). 25 opened new positions and 8 sold out.
- Funds holding
- 105
- Value held
- $175M
- New / sold out
- 25 / 8
- Net shares, same filers
- +0.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of FENC
Share of 13F holdings is each fund's shares as a share of the 16,313,727 FENC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- AIGH Capital Management LLC Added+$5.4M
- Prospect Capital Advisors, LLC New+$5.4M
- AWM Investment Company, Inc. Added+$4.7M
- BlackRock, Inc. Added+$3.9M
- Rosalind Advisors, Inc. Added+$3.0M
- Jane Street Group, LLC New+$2.5M
- Marshall Wace, LLP New+$1.5M
- Renaissance Technologies LLC New+$1.4M
- CenterBook Partners LP New+$1.3M
- Wellington Management Group LLP New+$909K
Biggest sellers in Q2 2026
- Southpoint Capital Advisors LP Sold out-$16.9M
- Solas Capital Management, LLC Trimmed-$6.4M
- Citadel Advisors LLC Trimmed-$888K
- Vanguard Capital Management LLC Trimmed-$622K
- Gendell Jeffrey L Sold out-$511K
- Squarepoint Ops LLC Trimmed-$273K
- Goldman Sachs Group Inc Trimmed-$239K
- Nano Cap New Millennium Growth Fund L P Trimmed-$151K
- Globeflex Capital L P Sold out-$113K
- HighTower Advisors, LLC Sold out-$92K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $40.8M and sold $26.4M; 44 added and 18 trimmed.
Schedule 13D and 13G filings on FENC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-04-28HIRSCHMAN ORIN SCHEDULE 13G filed by Fennec Pharmaceuticals Inc.Schedule 13G
Questions about FENC ownership
- Who owns FENC stock?
- 105 institutional investment managers reported FENC positions in their Form 13F filings for Q2 2026, holding 16,313,727 shares worth $175M in total. Rosalind Advisors, Inc. reported the largest position.
- Are funds buying or selling FENC?
- In Q2 2026, 25 managers opened new FENC positions, 44 added, 18 trimmed and 8 sold out. Managers that filed in both quarters added a net 113,571 shares.
- How current is this FENC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to FENC by CUSIP. Options are left out. FENC news and filings · FENC insider trades · Top funds